Six-Year Results from the Phase 3 Randomized Study Relevance Show Similar Outcomes for Previously Untreated Follicular Lymphoma Patients Receiving Lenalidomide Plus Rituximab (R (2)) Versus Rituximab-Chemotherapy Followed By Rituximab Maintenance

AuthID
P-00X-4CR
37
Author(s)
De Colella, JMS
·
Palomba, ML
·
Bachy, E
·
Fruchart, C
·
Libby, E
·
[+3]·
[+3]·
[+3]·
[+8]·
Cartron, G
·
Gkasiamis, A
·
Crowe, R
·
Xerri, L
·
Fowler, NH
·
Document Type
Abstract
Year published
2021
Published
in BLOOD, ISSN: 0006-4971
Volume: 138
Indexing
Publication Identifiers
Wos: WOS:000736413901148
Source Identifiers
ISSN: 0006-4971
Export Publication Metadata
Marked List
Info
At this moment we don't have any links to full text documens.
Name Order Name   Name Order Name   Name Order Name
1 Morschhauser, F;   2 Nastoupil, L;   3 Feugier, P;
4 De Colella, JMS;   5 Tilly, H;   6 Palomba, ML;
7 Bachy, E;   8 Fruchart, C;   9 Libby, E;
10 Casasnovas, RO;   11 Flinn, IW;   12 Haioun, C;
13 Maisonneuve, H;   14 Ysebaert, L;   15 Bartlett, NL;
16 Bouabdallah, K;   17 Brice, P;   18 Ribrag, V;
19 Le Gouill, S;   20 Daguindau, N;   21 Delwail, V;
22 Pica, GM;   23 Garcia Sancho, AM;   24 Lopez Guillermo, A;
25 Larouche, JF;   26 Ando, K;   27 Maria, GD;
28 Andre, M;   29 Wu, KL;   30 Sehn, LH;
31 Izutsu, K;   32 Cartron, G;   33 Gkasiamis, A;
34 Crowe, R;   35 Xerri, L;   36 Fowler, NH;
37 Salles, G;